Mechanisms involved in neutrophil accumulation induced by intradermal injection of interleukin‐1 (IL‐1) in the rabbit were investigated using intravenously‐injected 111In‐labelled neutrophils. C5a des Arg, N‐formyl‐methionyl‐leucyl‐phenylalanine (FMLP) and leukotriene B4 (LTB4) were included for comparison.
Local inhibition of protein biosynthesis in the skin using actinomycin‐D or cycloheximide blocked 111In‐neutrophil accumulation induced by IL‐1, but not that induced by the other mediators.
Actinomycin‐D and cycloheximide had no effect on local plasma protein leakage induced by intradermally‐injected C5a des Arg, or that induced by zymosan. 111In‐neutrophil accumulation induced by zymosan was, however, partially suppressed.
A monoclonal antibody, MoAb 60.3, recognising neutrophil surface CD18 antigen, was preincubated with 111In‐neutrophils before intravenous injection. This pretreatment did not affect circulating numbers of radiolabelled cells, but it inhibited their accumulation in response to IL‐1, C5a des Arg and the other mediators.
The results suggest that neutrophil accumulation induced by IL‐1, but not the other mediators, requires local protein biosynthesis, probably in the microvascular endothelium. Neutrophil accumulation to IL‐1 and the other mediators appears to require neutrophil surface antigen, CD18. The inflammatory response to zymosan may be mediated by both endogenous C5a des Arg and IL‐1.